by Professor C E Lumsden MD (Leeds) Only fifteen minutes' easy walking separates the Salpetriere from the Rue d'Ulm and only fifteen years separate Charcot's classical microscopical analysis of disseminated sclerosis from Pasteur's first human inoculation with anti-rabic vaccine. But a further seventy-four years were to elapse before the claim was to be made that anti-rabic vaccine can cause typical disseminated sclerosis (Shiraki & Otani 1959) . It was during these seventy-four years that the search for the cause, not of multiple sclerosis (M.S.), but of post-rabic vaccinal paralysis led to studies of the effects of neurovaccines which in turn led to the discovery, thirteen years ago, of the condition called experimental allergic encephalomyelitis (E.A.E.) . This in its turn has led during the past decade in rapid succession to the production of similar diseases affecting specifically the thyroid, adrenal, testis, uveal tract, peripheral nerves and skin, and to the postulate that these are all part of a general pathological phenomenon of auto-allergy which must play a vital role in the causation of many so-farunexplained human diseases. The heady finding that in some of these experimental diseases, and in certain spontaneous diseases in man, specific organor tissue-antibodies may occur in the blood has swelled the popularity of 'auto-immunity' as a clinical 'solution' for many pathogenetic mysteries. In view of the fact that the proceedings have been published of at least four Symposia (Grabar & Miescher 1959 , Kies & Alvord 1959 , Wolstenholme & O'Connor 1960 during the past two years largely devoted to immunopathology there seems little need here to review current notions of the experimental autoimmunity phenomena and it would seem now that the time has come to attempt a blueprint for a bridgehead on the human disease of multiple sclerosis. For this blueprint I suggest that there are three pressing questions to be discussed:
(1) What are we to conclude from the Uchimura-Shiraki (1957) cases ofpost-rabies vaccinal encephalomyelitis? (2) Do anti-brain antibodies occur in man and what is their significance? (3) Would it be possible to design a safe and effective 'vaccine' against experimental 'auto-immune demyelinating encephalitis' with a view to its eventual application to man both as a test for the autoimmunity hypothesis and as a possible form of therapy ?
(1) The histology of M.S. is well known, as also are Uchimura and Shiraki's cases of postrabies vaccinal encephalitis. Perhaps (Lumsden 1961 ) I am one of the few who do not accept Shiraki's cases as even acute M.S. -chiefly on the grounds that the inflammation and aedema are disproportionately great to the demyelination and lipid breakdown and that the lesions are evidently monophasic and non-progressive peripherally. But I concede that the Japanese cases (a) illustrate that the human brain is susceptible to as severe forms of confluent allergic leuco-encephalitis as the most susceptible laboratory animal, (b) that they teach that too much morphological diagnostic emphasis cannot be placed upon the size and sharpness of contours of lesions, and (c) that a neuro-allergic mechanism in man could go a long way to producing the morphological peculiarities of M.S. They make it hard for us to doubt that allergy may be, and seems likely to be, the factor which triggers off the process in the new plaque although the evidence so far does not warrant the conclusion that it is the cause of the progressive selective demyelination. In concentrating here on multiple sclerosis in relation to the auto-immunity theory I emphasize that I am thinking still of allergy only as an initiating or trigger mechanism for the plaques. But in explanation of the second phaseor continuation mechanismin the plaque I still believe, as I have urged for some years, that we still lack a vital clue, perhaps related to the biology of the oligodendrocyte. It is important to recognise that we mostly use the shorthand word 'myelin' for a complex structural unit consisting of a formed sheath of myelin with satellite nutrient cells.
(2) The second question may be stated in another way: Is there an immunological disturbance in multiple sclerosis and, if so, is it a cause or an effect ?
A priori, Kabat's demonstration of an abnormally high gamma globulin concentration in the C.S.F. of multiple sclerosis patients is suggestive of an immunological process. Moreover, there has been in recent years, particularly in Germany, a considerable revival of interest in early findings by Sachs & Steiner (1934) of substances in the sera of M.S. cases capable of fixing complement in the presence of extracts of M.S. brain tissue. They claimed that in 289 cases of M.S. 41 % gave positive results as against only 3 % in 1,340 controls. Raskin (1955) , from the U.S.A., using a battery of six 'antigens' obtained positive results in twice Steiner's frequency, viz. in 83% of 120 M.S. cases, but she obtained up to 42% positives in 101 control neurological cases. Frick's (1954) results, from Pette's laboratory, showed a good correlation with the activity of the disease in his 51 cases and a rather higher specificity. Delank (1957) in a series of 70 neurological cases of various types found that 40%5 had complementfixing antibodies to phenol-water and alcohol M.S. brain extracts and that these correlated with raised a and i globulins in the C.S.F. and he concluded that all these changes reflected 'a secondary defence reaction of the organism against breakdown products of brain tissue'. None the less his protocols show that even in the 12 M.S. cases in his series no fewer than 9 gave positive reactions as against the average of 40% in the whole series. Even more specific results were claimed by Steffen et al. (1955) using an anti-human globulindeviation technique. It is worth stressing that in all of these five investigations the effective antigens were obtained from multiple sclerotic brains whereas human brain tissue from normal or cerebral arteriosclerosis patients gave much lower positive rates in the studies of Steiner (1935) , Raskin (1955) , and Ahrengot (1957) and we likewise obtained negative results with lyophilized normal human (and animal) brain tissue tested against sera from 45 M.S. cases, including 6 suspected early cases and one neuromyelitis optica (Lumsden et al. 1950) .
Obviously the finding of circulating anti-brain antibodyeven if demonstrated to be suchdoes not prove that the disease is caused by it; if this were so we should have to define syphilis as a disease of man caused by antibodies to ox heart! And complement fixation is notoriously an unreliable method even in skilled hands. None the less, the results quoted attest to demonstrable immunological changes in multiple sclerosis and other diseases of the central nervous system and in one respect they are of great importance in that they show that antigenic material can escape from the brain in spontaneous diseases and elicit immunological responses. There is an interesting report by Read et al. (1939) of antibodies to white matter developing in the sera of schizophrenic patients following insulin shock that seems to be worth pursuing. Some have questioned the relevance of experimental allergic encephalitis to human disease on the grounds that the material has to be injected. These antibody studies in man therefore at least provide evidence for a built-in machinery for auto-antibody formation in man which should be followed up in view of what I shall say later about the anamnesticas opposed to the local adjuvantrole of tuberculin sensitivity in the experimental system.
Nor does it follow that all circulating antibodies which may in the future be demonstrated in man will necessarily be of this secondary nature. Other well-known auto-antibodiese.g. erythrocyte antibodies in auto-immune haemolytic anemiaalso required the discovery of specific sensitive methods for their detection. While Ahrengot's (1957) negative pilot test with the Boyden technique might be interpreted as due to the fact that the myelin antigens in his sera may be of the type lacking affinity for the red cell surface, it is possible to modify the surfaces of red cells (as with bisdiazotized benzidine) so that they will accept even these types of antigens so permitting the use of the highly sensitive haimagglutination technique in the search forantibody. This indirect coupling device has been used for anti-insulin antibody (Stavitsky & Arquilla 1955) and, cogently to the present argument, it has been used to demonstrate in the circulation the skinsensitizing antibody to ragweed extractthe classical type of tissue-fixed antibody comparable by assumption to the E.A.E. system (Sehon 1959) . But to apply such sensitive methods in the search for hypothetical primaryi.e. auto-aggressiveantibody in neurological conditions will require the isolation of chemically pure encephalitogenic proteins1. Some progress is being made as instanced by the report by Roboz-Einstein et al. (1960) of an encephalitogenically-active purespecies protein of strong positive charge in an electrical field which is present only in spinal cord and not in brain. Our group is working on this. This is a time of rapid revision in our ideas in immunology and the classical view that even delayed hypersensitivity of the tuberculin type is not associated with circulating antibody is open to question, partly on the instances just cited, and more recently on the instance of experimental allergic encephalitis itself. Notwithstanding the claim (Paterson 1960) early this year of the passive transfer of E.A.E. in rats by transfused lymphnode cells, we may have to think again about humoral factors. A few months ago Murray and her associates (Bornstein 1960) in New York, who have perfected the in vitro cultivation of myelin, claimed that this is a most sensitive system for demonstrating anti-myelin antibodies. The effects described were specific for the myelin sheath, were reversible and were not produced by control anti-kidney antibody prepared in the same way (an important control necessary to exclude possible Forssman antibody effects). If these findings are confirmed an important new immunological technique will be available for application to human sera for specific myelinolytic antibody. Indeed, if such a simple system as Murray's culture works, notwithstanding the earlier negative serum transfer work, one is tempted to ask whether we should now proceed to test sera (in-'The attempts of Soviet workers (Rempel 1956 , Kolesnikov 1957 , Kozlovski 1958 to use intradermal Margulis-Shubladze vaccine as a 'biological test' for M.S. are open to the same interpretation at the moment as the Sachs-Steiner antibodies just discussedi.e. they will demonstrate secondary anti-brain antibodies. Purified antigens may be the solution.
cluding human M.S. sera) on animals immunologically suppressed with whole body irradiation.
(3) In 1949 the accidental finding was reported (Lumsden 1949 ) that guinea-pigs treated with Freund adjuvants and either adrenal tissue or alcohol extract of brain, when later challenged with the standard encephalitogenic system, proved to be highly resistant. This observation has attracted only recent attention (Kies & Alvord 1958 , Svet-Moldavsky et al. 1960 ) probably because it was assumed to represent a minor secondary event due to the rejection of the inoculum by the operation of the Koch phenomenon. When, with Dr. Richard Blight, this work was resumed in Leeds two years ago, and before the appearance of the first of the Russian papers, with a 'safe-forman' vaccine in mind it seemed to us that the experiments should be broadly designed to find clues rather than support any theory. The experiments indicated in Table 1 are multi-faceted and in this discussion we need deal only with the broad result. We can largely ignore the results of group 1 -the Moldavsky-type experimentswhere the effects, especially of too short a course of pretreatment, emerge. Clinically, however, the protective effect of even an abridged course of adjuvants, both with and without foetal brain, is marked, although the microscope shows that most of the aniimals had subclinicaland histologically milderlesions. But this method has provided a rather sensitive system for detecting enhancement of the adjuvant protection by the addition of human feetal brain.
In the other groups, the use of a longer pretreatment and an homologous brain tissue in the challenge has had the effect of separating much more clearly the protective effect from its absence. The conclusions to be drawn from scrutiny of the results of the combined groups 2-6 are clear. Whereas, in accordance with previous experience, the natural resistance of the guinea-pigs to the disease (as screened histologically) is seen to be 10% -and which to allow a margin of safety may be doubled to 20 % -when suitable pretreatment is given this figure can be raised to 80% and, clinically, the protection can be almost complete. Moreover, in all series where paraffin, lanolin and heat-killed M. tuberculosis were used as adjuvants, it is the adjuvants which evidently confer the protection. For this reason the small series in group 6 becomes of great interest since here none of the Freund adjuvants were used but an unrelated simple chemical substance, sodium alginate, with brain tissue.
It is premature to speculate on the conclusions to be drawn from these experiments other than the clear-cut result that this disease, to which guinea-pigs are almost completely susceptible, can be nearly completely prevented. Further experiments are in hand but since one does not embark Table I Summary of results of 'vaccination' against experimental 'allergic' encephalomyelitis Previously unpublished results by Lumsden & Blight (1961) showing the protective effects of various pre-treatments and the absence of protection by pre-treatment with BCG 28 11 84 * Group 1 were challenged with three 1 ml injections at weekly intervals of a 10 % rabbit brain and cord mixture with Freund adjuvants.
All other groups were challenged with 1 ml weekly for three weeks of a 10% guinea-pig brain and cord emulsion in Freund's adjuvants (liquidiparaffin,tlanolin, 5 mg heat-killed M. tuberculosis per ml).
,on experiments on hundreds of animals without much careful self-questioning, I can in conclusion advance some tentative notions. Into what category of 'immunological unresponsiveness' shall we try to fit these results?
(1) Is this Felton's 'immunologic paralysis' in the sense of deviation or fixation of any free antibody as soon as it is formed before it gets to the brain ? This view seems untenable since Freund adjuvants without brain were so highly protective. Nor, in the instance of the alginate protection, must it be assumed that the brain component necessarily acts by 'deviation' since in two of the animals a total of 20 mg only of brain was used in the pretreatment phase (details to be published elsewhere).
(2) Is this 'immunological tolerance' established in the adult? This again seems improbable be--cause of the lack of complete specificity.
(3) Is this true 'acquired immunity' to E.A.E.? If E.A.E. is caused by antibody it is untenable that antibody can elicit an anti-antibody. If, however, the disease were due not to circulating antibody but to circulating antigen-antibody complex this explanation might be possible, although I know of no precedent.
(4) Is this the result of the 'Koch phenomenon'?
The challenge injections are sited differently from the pretreatment injections. In view of this, group 4 -the animals pretreated with B.C.G. without brain and confirmed to be Mantoux-convertedare comparable with the protected groups. Yet these B.C.G. animals showed no protection whatsoever and at the same time presented local Koch phenomena at the injection sites far exceeding any seen in the series protected with Freund adjuvants. Moreover, the role of a Koch phenomenon cannot be advanced for the results with alginate unless we postulate that the Koch phenomenon is not strictly specific. On the other hand if we invoke the Koch phenomenon -in this protection theory as operating not locally in rejection of-the inoculum but generally upon the immunologicallycompetent cells in the lymph nodes or already in the circulation (those 'messengers of death' responsible in Waksman's (1960) explanation of E.A.E.), then again we are confronted by the fact that B.C.G. pretreatment, comparably timed, failed to protect and even apparently accelerated the encephalitis. It may be argued that perhaps the dose of B.C.G. fails to provide the strong stimulus to the lymph nodes that Freund's adjuvants and alginate plus brain provide. This we must investigate but even if it proves to be true the result is no less important since it would imply that by suppressing the immunologically-competent cells in the lymphoid system by massive antigen challenge of one type, antibody formation to the brain (and by inference to auto-antigen) may be prevented. It has always been a tenet that E.A.E. can be regularly induced only when the brain tissue and Freund adjuvants are injected together. Yet in the protection situation equally regularly is it sufficient to modify the immunological response to the adjuvant alone; and even this may be achieved non-specifically since pretreatment with alginate and brain confers resistance to a subsequent challenge containing tuberculoprotein as its essential adjuvant agent. We may be guilty in studies of hypersensitivity of the delayed type -to which all the experimental autoallergic diseases seem to belong -of invoking too rigidly the classical concepts of immunological specificity, applicable where antibody molecules but not the immunologically-competent cells primarily dictate the result. E.A.E. may well be a true auto-antibody disease to neural protein acting as a complete (i.e. non-haptenic) antigen but elicited only as an anamnestic response to tuberculin, and M.S. might be a true auto-antibody disease elicited, in a patient in an anamnestic state, by nervous antigens liberated as we saw earlier (under Question 2) in a variety of conditions. Therefore, clinically, perhaps we should in M.S. examine more closely the patient's general immunological responsiveness, e.g. to tuberculoprotein (the Oxford findings of Smith et al. 1957 may be interpretable in this light) and our research and therapeutic hopes should be focused not so much on anti-brain antibodies as upon an anamnestic mechanism on which their operation as auto-aggressive antibodies may be dependent.
Experimental Allergic Encephalomyelitis by E J Field MD MS (Newcastle upon Tyne)
Since the century or so during which multiple sclerosis has been recognized has brought virtually no progress in elucidating its etiology, the announcement by Rivers, Sprunt & Berry in 1933 of experimental production of demyelinating disease in animals was hailed with hope as well as interest. Whilst their original method involved repeated injections (up to 60 or 70) of brain substance before neurological disturbance appeared, the introduction of adjuvants by Freund and his collaborators in the early 1940s made the production of experimental encephalomyelitis much easier; and when guinea-pigs were shown to be highly susceptible to the experimental disease, laboratories in all parts of the world embarked upon such work. Because Freund's adjuvants (consisting of a light mineral oil, heat killed and dried tubercle or other suitable bacilli, and an emulsifying agent) are known to increase antibody production when injected together with any given antigen, and because of the interval of two to three weeks between injection and onset of neurological disturbance, the condition has come to be looked upon as an experimental allergic encephalomyelitis (E.A.E.) though this has never been proved.
Whilst guinea-pigs and rabbits are most commonly used, monkeys, dogs, sheep and other animals have all been shown to respond and an inadvertent similar experiment has been successfully carried out on man.
My own experiments have been confined to guinea-pigs. A single inoculum into the skin of the dorsum of one foot, consisting of 15 mg of wet normal brain (either human or guinea-pig) with 1 mg of heat killed and dried tubercle bacilli with Bayol F & Arlacel A (a light Esso mineral oil and an emulsifying agent respectively) is made in a volume of 0-2 ml. Within a few days the foot becomes swollen and often ulcerates. At about fourteen to twenty days the animal begins to show neurological disturbance. The hind legs become weak and sometimes rather stiff, and the animal is easily thrown off balance. Nearly always there is a loss of weight of 20-30 g on the day of paresis or on the preceding day. The condition may deteriorate so that the animal comes to drag its hind Jegs whilst its forepart remains quite well; or paralysis may ascend and the animal lie permanently on its side, sometimes showing a continuous tremor or occasional convulsions, especially when handled. Many very sick animals will nevertheless recover, and if paralysis has not been severe they may finally show little more than a persisting slight stiffness of the hind legs. At the height of the illness paralysis of bladder and rectal sphincters is common. About 80-90 % of all guinea-pigs show some degree of neurological disturbance after the injection described above.
Two important questions may be posed: (1) Is so-called experimental 'allergic' encephalomyelitis truly of an allergic nature? (2) If so, what relation does it bear to human diseases such as post-infectious encephalomyelitis and multiple sclerosis?
Whilst the allergic nature of the condition has not been established beyond all doubt, it is generally agreed to be highly probable. The activity of Freund's adjuvants which are known to promote the development of antibodies and tuberculin type sensitivity, the characteristic two to three weeks latent period following injection, the specific efficacy of myelin-containing brain material and the induction of 'tolerance' by injection of brain material into immature animals are the major bases for this belief. However, attempts to demonstrate antibody to brain tissue in the blood during the experimental disease have uniformly failed to establish any correlation between the blood titre and severity of the disease. Animals may be severely ill without antibody being detectable. On the other hand skin sensitivity to the brain material originally injected has been said to parallel the severity of disease. In my own experience such correspondence is, however, only approximate. Practically every animal becomes sensitive to the inoculated heterologous brain, often within forty-eight to seventy-two hours of the injection, while the reaction obtained on skin testing (which is of the delayed tuberculin type) commonly shows little relation to the severity of the disease. Some further difficulties will be considered below.
It is impossible within the limits of this brief presentation to deal with more than a very few isolated aspects of experimental allergic encephalitis.
Pathology: This varies in different species. All show perivascular cuffing with small round cells (lymphocytes) and some authors have also seen plasma cells and occasionally polymorphonuclear leucocytes too. Of more interest is the occurrence of true demyelination. This undoubtedly occurs in monkeys (and in man, as will be seen below),
